Red Clover Menopause Meta-analysis: What the Evidence Says

Red Clover Menopause Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are syst

3 min read · 556 wordsReviewed August 2026
A vibrant expanse of green clover leaves forming a dense natural carpet. Ideal for nature and botanical themes. - Evidence evidence guide for red clover menopause meta-analysis
Photo by Airam Dato-on on Pexels · Pexels License

Quick Answer

Red Clover Menopause Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 1 systematic review, 1 preclinical study.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Red Clover Menopause Meta-analysis: What the Evidence Says

Quick Answer

Red Clover Menopause Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 1 systematic review, 1 preclinical study.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis systematic review 1 2025-12-08 10.3390/healthcare13243206
Natural strategies to optimize estrogen levels in aging women: mini review preclinical study 4 2025-11-25 10.3389/fragi.2025.1706117

What The Sources Report

  • Common physical symptoms include decreased skin elasticity, reduced libido, headaches, cardiovascular issues, hot flashes, sleep disturbances, and facial flushing. [Kim Ji-Hyun (2025); evidence level 1]
  • Psychological symptoms frequently include increased irritability and depressive symptomatology, such as feelings of worthlessness, fatigue, lack of motivation, and diminished concentration. [Kim Ji-Hyun (2025); evidence level 1]
  • Hulteen et al., 2023 Davis and Baber, 2022 Zhu et al., 2020 The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel, 2022 Newson, 2016 Depypere et al., 2016 Franco et al., 2016 Estrogen deficiency after menopause accelerates chronic disease risk and diminishes quality of life. [Bolgova Olena (2025); evidence level 4]
  • Epidemiological data demonstrate that women experiencing severe vasomotor symptoms have a 1.5-fold increased risk of coronary heart disease and stroke compared to asymptomatic women. [Bolgova Olena (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For red clover menopause meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

  • Kim Ji-Hyun (2025). Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. DOI: 10.3390/healthcare13243206. PMCID: PMC12732411. PMID: 41464280. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12732411/
  • Bolgova Olena (2025). Natural strategies to optimize estrogen levels in aging women: mini review. DOI: 10.3389/fragi.2025.1706117. PMCID: PMC12685915. PMID: 41377590. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12685915/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed August 14, 2026 by Migaku Evidence Review

← All GuidesSupplement Reference →